Organon (NYSE: OGN) reported Q1 EPS of $1.08, $0.07 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.53 billion.

For earnings history and earnings-related data on Organon (OGN) click here.